Download presentation
Presentation is loading. Please wait.
Published byRalf Simpson Modified over 9 years ago
1
Case # 31 M.C., a 60y/o male, has already been experiencing nausea, vomiting & diarrhea aside from having developed PNEUMONIA while in the hospital. Lab exams and his other manifestations revealed that the patient is already suffering from SEPSIS.
2
“Pneumonia while in the hospital” Dx: Hospital Acquired Pneumonia (HAP) NOSOCOMIAL INFECTION, an infection that was not found present prior to hospital admission (w/in 48 hrs.) Specific type: 64% isolated from the lung of the pt were GRAM (+) cocci S. Aureas BUT My suspect: GRAM (-) bacilli P. Aeroginosa MOT: Contact, Airborne, Vehicle and or Vector (prevention UNIVERSAL PRECAUTION) CDC staff handwash enough? NICU 29% ICU 81% WARD 16% Think? INSIDE THE BOX OUTSIDE THE BOX Possible due to? NOT IN OUR HISTORY Dx: Pneumonia (but hospital acquired type in Hx) Gram(-) GIT ?Endotracheal Intubation, nasogastric tubing or enteral feeding ASPIRATION P.:Indwelling catheter Gram(+) nose,Skin ?Bacteria,Viral,Fungi COMMUNITY ACQUIRED P. Other organism 21%P.Aeroginosa,9%Enterob acter or 8%K.Pneumonia
3
DIAGNOSTIC ACCURACY “controversial” bec. We have to be certain what organism or PNEUMONIA is really present. LAB Dx: endotracheal aspiration, FOB fiberoptic bronchoscope, gram staining, BBS blinded bronchial sampling. Sensitivity of this test ave. 95%
4
Empirical Antibiotic Tx for HAP Have to understand the local patterns of anti- bacterial resistance. If MRSA prevalent in the institution, Vancomycin should be included can also use Quinupristin- dalfopristin and linezolid. KEY “broaden the spectrum of antibacterial treatment and continued lab testing” DOC P.Aeruginosa = Carbencillin + Aminoglycoside
5
STOP! DO NOT FORGET! SEPSIS most often complication of HAP, so follow regimen for proper medication administration. Electrolyte imbalance due to vomitting and diarrhea.
6
t.y.
7
Pulmonary Infections Occurs in: a. Loss or suppression of cough reflex b. Injury to the mucocilliary apparatus c. Interference with the phagocytic or bacterial action of alveolar macrophages d. Pulmonary congestion and edema e. Accumulation of secretion
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.